STAT3 is activated in a subset of the Ewing sarcoma family of tumours

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Pathology

• Publication date

  2006-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/path.1941PMID 16463269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ewing sarcoma / Primitive neuroectodermal tumour (PNET)

  2006cited by this paper
• Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors

  2005cited by this paper
• A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells

  2005cited by this paper
• Activation status of the JAK/STAT3 pathway in mantle cell lymphoma.

  2005cited by this paper
• Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice.

  2005cited by this paper
• Ewing Sarcoma Family of Tumors

  2005cited by this paper
• Nuclear Receptors as Negative Modulators of STAT3 in Multiple Myeloma

  2005cited by this paper
• SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition

  2005cited by this paper
• Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma

  2005cited by this paper
• Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target

  2005cited by this paper
• A Novel Platinum Compound Inhibits Constitutive Stat3 Signaling and Induces Cell Cycle Arrest and Apoptosis of Malignant Cells*

  2005cited by this paper
• Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells

  2005cited by this paper
• Overexpression of Phosphorylated‐STAT3 Correlated with the Invasion and Metastasis of Cutaneous Squamous Cell Carcinoma

  2005cited by this paper
• The STATs of cancer — new molecular targets come of age

  2004cited by this paper
• Methylation of SHP1 gene and loss of SHP1 protein expression are frequent in systemic anaplastic large cell lymphoma.

  2004cited by this paper
• Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines.

  2004cited by this paper
• SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway.

  2004cited by this paper
• Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols

  2004cited by this paper
• Selective inhibition of STAT3 induces apoptosis and G1 cell cycle arrest in ALK-positive anaplastic large cell lymphoma

  2004cited by this paper
• RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells

  2004cited by this paper
• EWS/FLI-1 Silencing and Gene Profiling of Ewing Cells Reveal Downstream Oncogenic Pathways and a Crucial Role for Repression of Insulin-Like Growth Factor Binding Protein 3

  2004cited by this paper
• Inhibition of gp130 Signaling in Breast Cancer Blocks Constitutive Activation of Stat3 and Inhibits in Vivo Malignancy

  2004cited by this paper
• Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis

  2004cited by this paper
• Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity.

  2004cited by this paper
• Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma.

  2003cited by this paper
• Clear cell ependymoma: A clinicopathologic and radiographic analysis of 10 patients

  2003cited by this paper
• Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.

  2003cited by this paper
• Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.

  2003cited by this paper
• Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis

  2003cited by this paper
• Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma.

  2003cited by this paper
• Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth

  2003cited by this paper
• Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines

  2003cited by this paper
• Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.

  2002cited by this paper
• Suppressors of cytokine signalling: SOCS

  2002cited by this paper
• Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

  2002cited by this paper
• Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.

  2002cited by this paper
• World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone

  2002cited by this paper
• Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival.

  2002cited by this paper
• Stat3 activation in prostatic carcinomas

  2002cited by this paper
• Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells

  2001cited by this paper
• Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

  2001cited by this paper
• The suppressors of cytokine signalling (SOCS)

  2001cited by this paper
• STAT signaling in head and neck cancer

  2000cited by this paper
• The Splicing Factor U1C Represses EWS/FLI-mediated Transactivation*

  2000cited by this paper
• The role of STATs in transcriptional control and their impact on cellular function

  2000cited by this paper
• STAT signaling in the pathogenesis and treatment of leukemias

  2000cited by this paper
• Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.

  1999cited by this paper
• Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.

  1999cited by this paper
• Stat3 as an oncogene.

  1999cited by this paper
• P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo.

  1996cited by this paper
• Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?

  1996cited by this paper
• A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS–family transcription factor, ERG

  1994cited by this paper
• Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data.

  1994cited by this paper
• Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.

  1993cited by this paper
• Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation.

  1993cited by this paper
• Combinatorial generation of variable fusion proteins in the Ewing family of tumours.

  1993cited by this paper
• Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

  1992cited by this paper
• Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints

  1992cited by this paper
• Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.

  1992cited by this paper

• The Rat Sarcoma Virus (RAS) Family of Proteins in Sarcomas

  2024cites this paper
• Whole genome profiling of rare pediatric thoracic tumors elucidates a YAP1::LEUTX fusion in an unclassified biphasic embryonal neoplasm.

  2024cites this paper
• Molecular and biologic biomarkers of Ewing sarcoma: A systematic review

  2023cites this paper
• CRISPR-Cas9 knockout screening identifies KIAA1429 as an essential gene in Ewing sarcoma

  2023cites this paper
• Case Report: Identification of a novel STAT3 mutation in EBV-positive inflammatory follicular dendritic cell sarcoma

  2023cites this paper
• PLCG2 as a potential indicator of tumor microenvironment remodeling in soft tissue sarcoma

  2021cites this paper
• A comprehensive review on anticancer mechanism of bazedoxifene

  2021cites this paper
• The Role of Tyrosine Kinases as a Critical Prognostic Parameter and Its Targeted Therapies in Ewing Sarcoma

  2020cites this paper
• Immunopathology of Kikuchi–Fujimoto disease: A reappraisal using novel immunohistochemistry markers

  2019cites this paper
• PTPRD copy number variants and Ewing's sarcoma: Strengthening the association and therapeutic implications.

  2019cites this paper
• Caracterització funcional de LOXL2 en el rabdomiosarcoma alveolar

  2018cites this paper
• Discovery of Surface Target Proteins Linking Drugs, Molecular Markers, Gene Regulation, Protein Networks, and Disease by Using a Web-Based Platform Targets-search.

  2018cites this paper
• Identification and analysis of key genes in osteosarcoma using bioinformatics

  2017cites this paper
• Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma

  2017cites this paper
• Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway

  2016cites this paper
• RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-κB pathway, independently of the fusion oncoprotein

  2016cites this paper
• Chronic diseases caused by chronic inflammation require chronic treatment: The anti-inflammatory lifestyle

  2016cites this paper
• Persistent GP130/STAT3 Signaling Contributes to the Resistance of Doxorubicin, Cisplatin, and MEK Inhibitor in Human Rhabdomyosarcoma Cells.

  2016cites this paper
• Targeted therapies for advanced Ewing sarcoma family of tumors.

  2015cites this paper
• Novel Secondary Somatic Mutations in Ewing's Sarcoma and Desmoplastic Small Round Cell Tumors

  2014cites this paper
• Molecular and Cellular Pathobiology Suppression of Deacetylase SIRT 1 Mediates Tumor-SuppressiveNOTCHResponse andOffers aNovel Treatment Option in Metastatic Ewing Sarcoma

  2014cites this paper
• Chromatin , Gene , and RNA Regulation PhosphoproteomicPro fi lingReveals IL 6-MediatedParacrine Signaling within the Ewing Sarcoma Family of Tumors

  2014cites this paper
• Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma.

  2014cites this paper
• Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy

  2014cites this paper
• Phosphoproteomic Profiling Reveals IL6-Mediated Paracrine Signaling within the Ewing Sarcoma Family of Tumors

  2014cites this paper
• Germline PTPRD Mutations in Ewing Sarcoma: Biologic and Clinical Implications

  2013influential citation
• Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis

  2013cites this paper
• STAT3 Regulates Proliferation and Immunogenicity of the Ewing Family of Tumors In Vitro

  2012cites this paper
• Anti-Angiogenic Activity of a Small Molecule STAT3 Inhibitor LLL12

  2012cites this paper
• Inflammation: What role in pediatric cancer?

  2012cites this paper
• Prognostic significance of STAT3 and phosphorylated STAT3 in human soft tissue tumors - a clinicopathological analysis

  2011cites this paper
• Establishment of a Ewing's sarcoma mouse model

  2011cites this paper
• The immune response in paediatric cancer

  2010cites this paper
• Blockage of Stat3 With CDDO-Me Inhibits Tumor Cell Growth in Chordoma

  2010cites this paper
• Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway

  2010cites this paper
• Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated‐Stat3 correlates with poor prognosis

  2010cites this paper
• Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells.

  2010cites this paper
• Caveolin-1 Modulates the Ability of Ewing's Sarcoma to Metastasize

  2010cites this paper
• Inhibition of the Insulin-Like Growth Factor I Receptor by Epigallocatechin Gallate Blocks Proliferation and Induces the Death of Ewing Tumor Cells

  2010influential citation
• Characterization of STAT3 activation and expression in canine and human osteosarcoma

  2009cites this paper
• The expression of epidermal growth factor receptor and its downstream signaling molecules in osteosarcoma.

  2009cites this paper
• Personalized therapy of sarcomas: Integration of biomarkers for improved diagnosis, prognosis, and therapy selection

  2008cites this paper
• Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors.

  2007cites this paper
• Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cells

  2007cites this paper
• Ewing sarcoma‐family tumors that arise after treatment of primary childhood cancer

  2006cites this paper
• Expression and genomic status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcoma

  2006cites this paper
• Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma

  2006cites this paper
• Targeting Signal‐Transducer‐and‐Activator‐of‐Transcription‐3 for Prevention and Therapy of Cancer

  2006cites this paper
• Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways.

  2006cites this paper